Abstract
Activated immune cell infiltration into organs contributes to the development and maintenance of hypertension. Studies targeting specific immune cell populations or reducing their inflammatory signalling have demonstrated a reduction in BP. Lymphatic vessels play a key role in immune cell trafficking and in resolving inflammation, but little is known about their role in hypertension. Studies from our laboratory and others suggest that inflammation-associated or induction of lymphangiogenesis is organ protective and anti-hypertensive. This review provides the basis for hypertension as a disease of chronic inflammation in various tissues and highlights how renal lymphangiogenesis is a novel regulator of kidney health and BP. Linked Articles: This article is part of a themed section on Immune Targets in Hypertension. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.12/issuetoc.
Cite
CITATION STYLE
Balasubbramanian, D., Lopez Gelston, C. A., Rutkowski, J. M., & Mitchell, B. M. (2019, June 1). Immune cell trafficking, lymphatics and hypertension. British Journal of Pharmacology. John Wiley and Sons Inc. https://doi.org/10.1111/bph.14370
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.